Association of periorbital melanosis with pigmentary demarcation line-F

Authors

  • Muhammad Shahid
  • Kehkshan Tahir

DOI:

https://doi.org/10.66344/jpad.28.1.2018.1198

Keywords:

Periorbital melanosis, pigmentary demarcation lines, Wood’s lamp examination

Abstract

Objective To determine the association of periorbital melanosis with pigmentary demarcation line-F. Methods This observational study was carried out at the Department of Dermatology, Services Institute of Medical Sciences/ Services Hospital Lahore, from January 2017 to June 2017. A total of 50 patients of periorbital melanosis of any age and either sex were included. The association between periorbital melanosis (POM) and pigmentary demarcation line-F (PDL-F), if present, was determined by close inspection of the patients, histopathological and Wood’s lamp examination. Results In 44 (88%) patients, PDL-F was observed along with POM. Histopathological examination carried out on 5 patients showed melanin pigment within dermal macrophages in both POM and PDL-F. In 9 (18%) patients, both POM and PDL-F became indiscernible on Wood’s lamp examination. Conclusion POM and PDL-F are common chronic and same pigmentary conditions and should be considered as a single entity. 

References

Sarkar R. Idiopathic cutaneous hyperchromia at the orbital region of periorbital hyperpigmentation. J Cutan Aesthet Surg. 2012;5:183-4.

Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S, Bansal S. Periorbital hyperpigmentation: a comprehensive review. J Clin Aesthet Dermatol. 2016;9:49-55.

Huang YL, Chang SL, Ma L, Lee Mc, Hu S. Clinical analysis and classification of dark eye circle. Int J Dermatol. 2014;53:164-70.

Malakar S, Lahiri K, Banerjee U, Mondal S, Sarangi S. Periorbital melanosis is an extension of pigmentary demarcation line-F on face. Indian J Dermatol Venereol Leprol. 2007;73:323-5.

Chan R, Park KC, Lee MH, Lee ES, Chang SE, Leow YH et al. A randomized control trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. Br J Dermatol. 2008;159:697-703.

Momosawa A, Kurita M, Ozaki M, Miyamoto S, Kobayashi Y, Ban I et al. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. Plast Reconstr Surg. 2008;121:282-8.

Gracia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22:443-7.

Somani VK, Razvi F, Sita VV. Pigmentary demarcation lines over the face. Indian J Dermatol Venereol Leprol. 2004;70:336-41.

Krive JM. How common is pigmentary mosaicism? 1997;133:527-8.

Maleville J, Taoeb A. Pigmentary demarcation lines as markers of neural development. Arch Dermatol. 1997;133:1459.

Singh N, Thappa DM. Pigmentary demarcation lines. Pigment Int. 2014;1(1):13-6.

Al-Samary A, Al-Mohizea S, Bin-Saif G, Al-Balbeesi A. Pigmentary demarcation lines on the face in Saudi women. Indian J Dermatol Venereol Leprol. 2010;76:378-81.

Sheth PB, Shah HA, Dave JN. Periorbital hyperpigmentation: a study of its prevalence, common causative factors and its association with personal habits and other disorders. Indian J Dermatol. 2014;59:151-7.

Goodman RM, Belcher RW. Periorbital hyperpigmentation. An overlooked genetic disorder of pigmentation. Arch Dermatol. 1969;100:169-74.

Ranu H, Thung S, Goh BK, Burger A, Goh CL. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification. Dermatol Surg. 2011;37:1297-303.

Watanabe S, Nakai K, Ohnishi T. Condition known as “dark rings under the eyes†in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser. Dermatol Surg. 2006;32:785-9.

Downloads

Published

2018-07-23

How to Cite

1.
Shahid M, Tahir K. Association of periorbital melanosis with pigmentary demarcation line-F. J Pak Assoc Dermatol [Internet]. 2018Jul.23 [cited 2026Apr.30];28(1):39-44. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1198

Issue

Vol. 28 No. 1 (2018): January - March

Section

Original Articles

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.